Watch the webinar

Unlike the software business, Medtech startups face more complex regulatory hurdles before bringing their products to market. As an investor, the clinical trials and approval path can seem like a black box and as a result, many investors shy away from investing in this space.

In this webinar, Friederike Reinl explains how a VC assesses Medtech startups and the basics you need to be able to evaluate an investment in this highly interesting space.